NAP
OME

New Amsterdam Partners’s Omega Protein OME Stock Holding History

New Amsterdam Partners’s Portfolio OME Stock Details OME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-157,523
Closed -$2.82M – 136
2017
Q2 		$2.82M Buy
157,523
+22,960
+17% +$429K 0.6% 62
2017
Q1 		$2.7M Sell
134,563
-11,112
-8% -$259K 0.64% 65
2016
Q4 		$3.65M Sell
145,675
-1,494
-1% -$35.3K 0.83% 54
2016
Q3 		$3.44M Buy
147,169
+6,014
+4% +$141K 0.79% 59
2016
Q2 		$2.82M Buy
+141,155
New +$2.63M 0.69% 63
2015
Q3 		– Sell
-323,706
Closed -$4.45M – 145
2015
Q2 		$4.45M Sell
323,706
-4,288
-1% -$57K 0.38% 61
2015
Q1 		$4.49M Buy
327,994
+1,294
+0.4% +$14.9K 0.36% 64
2014
Q4 		$3.45M Sell
326,700
-12,027
-4% -$142K 0.3% 85
2014
Q3 		$4.23M Buy
338,727
+46,569
+16% +$649K 0.28% 59
2014
Q2 		$4M Buy
292,158
+113,865
+64% +$1.49M 0.26% 61
2014
Q1 		$2.15M Buy
178,293
+34,207
+24% +$392K 0.15% 105
2013
Q4 		$1.77M Buy
+144,086
New +$1.69M 0.12% 105

Other funds holding OME

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

New Amsterdam Partners's OME Position: Q3 2017 in Review

New Amsterdam Partners sold out of Omega Protein (OME) in Q3 2017, closing a stake of 157,523 shares — an estimated $2.82M sold.

New Amsterdam Partners first reported a position in OME in Q4 2013 and held it in 12 quarters. The position peaked at $4.49M in Q1 2015. 122 funds tracked by Wall St. Rank hold OME as of Q3 2017.

  • New Amsterdam Partners reported no remaining Omega Protein position as of Q3 2017 after selling out during the quarter.
  • New Amsterdam Partners sold 157,523 Omega Protein shares in Q3 2017, an estimated $2.82M.
  • New Amsterdam Partners first reported a position in Omega Protein in Q4 2013 and held it in 12 quarters.
  • New Amsterdam Partners's Omega Protein position peaked at $4.49M in Q1 2015.
  • 122 funds tracked by Wall St. Rank held Omega Protein as of Q3 2017.

Based on New Amsterdam Partners's 13F filing for Q3 2017, filed 2 Nov 2017.